Vista Partners Updates Coverage; Maintains $3.20 Ta... (absence of drugsof abuse in oral fluids....)

(Date:11/19/2009)...TLE, Nov. 19 Omeros Corp... financial results for the third quarter ended Sep...ber 30, 2009, Omeros reported a net loss of $3.9 m...oss of $7.4 million, or $2.54 per share, for the s...ember 30, 2009, the Company reported a net loss of...

(Date:11/19/2009)... ,, BETHESDA, Md., Nov. 19 /PRNewswire-FirstCa...nnovator in biotechnology for diabetes therapy, an...g services to food, supplement, biotechnology and ...d the previously reported $6.3 million registered ...60,870 shares of its common stock and warrants to ...

(Date:11/19/2009)...ESDA, Md., Nov. 19 Spher...biotechnology for diabetes therapy, and a provider...o food, supplement, biotechnology and pharmaceutic...ay,s Annual Meeting of Shareholders. ,, At the ...daq: SPEX ) elected the following members to the ...

(Date:11/19/2009)... MUNSTER, Germany, November 19 M...d on November 16th, 2009 Flibanserin in the,indica...a in Parkinson,s,disease for orphan drug status de...). Levodopa-induced dyskinesia is a complication o...nd a serious burden to some of those,affected, sin...

Breaking Biology Technology:Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2 Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3 Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4 Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5 Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6 Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7 Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8 Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2 Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3 Spherix Announces Results of Annual Shareholders Meeting 2 Spherix Announces Results of Annual Shareholders Meeting 3 Spherix Announces Results of Annual Shareholders Meeting 4 MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2

[0] Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights [0] Spherix Announces the Closing of $6.3 Million Registered Direct Offering [0] Spherix Announces Results of Annual Shareholders Meeting [0] MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug"

... Wis. - Pitney Bowes, a mail and document managem...cquire data-quality management company Firstlogic...stlogic,s outstanding shares, it was announced on ...nt ramifications of the deal won,t be known under ...s expected to close in the third calendar quarter ...

...is . -- Esker Software has added fax reception to ...r on Demand will be able to receive faxes directl...very service, Esker on Demand enables users of the...ng of their business documents. Users are invoiced... of inbound faxing, we have closed the loop to cre...

...is. - Startup entrepreneurs throughout the Upper ...ps about securing venture capital at the Wisconsi... at the Monona Terrace in Madison, will run from O...Technology Council, the Wisconsin Innovation Netwo...Entrepreneurs, Network. , ,"When you think about i...

Other Biology Technology:Pitney Bowes to acquire Firstlogic 2 Conference will focus on financing of early-stage ventures 2 Conference will focus on financing of early-stage ventures 3

Pitney Bowes to acquire Firstlogic Esker adds fax reception to on-demand service Conference will focus on financing of early-stage ventures

(Date:11/20/2009)...earchers report that a class of heart medications ...l, effect on the heart, depending on their molecul...ournal Circulation Research , found that beta-blo...rs on the heart muscle offer the most benefit to c...beta-receptors can actually undermine the structur...

(Date:11/19/2009)...evealing the genetic instructions inside corn, one...s one of the most complex sequences of DNA ever an...icist David Schwartz, who was one of more than 100..., "The maize genome is a true maze full of conf...ld-be sequencers for years," says Schwartz. , Pu...

(Date:11/19/2009)...sity in maize, also known as corn, researchers acr...hat should pave the way to significant improvement... animal feed and fiber around the world. , The n...otype map, charts genetic diversity and recombinat... The research team, led by U.S. Department of Agri...

Breaking Biology News(10 mins):Carvedilol shown to have unique characteristics among beta blockers 2 Sweet corn story begins in UW-Madison lab 2 Sweet corn story begins in UW-Madison lab 3 Substance Abuse Expert Dr Drew Joins Forces with the Five Moms to Raise Awareness About OTC Cough Medicine Abuse Among Teens 59825 1 Substance Abuse Expert Dr Drew Joins Forces with the Five Moms to Raise Awareness About OTC Cough Medicine Abuse Among Teens 59825 2 Substance Abuse Expert Dr Drew Joins Forces with the Five Moms to Raise Awareness About OTC Cough Medicine Abuse Among Teens 59825 3 New Study Details Complex Health Care Needs of Medicaids Highest Need Highest Cost Populations 59821 1 New Study Details Complex Health Care Needs of Medicaids Highest Need Highest Cost Populations 59821 2 New Study Details Complex Health Care Needs of Medicaids Highest Need Highest Cost Populations 59821 3 Celsis IVT Granted U S Patent for LiverPool 28TM 29 Hepatocytes 14543 1 Celsis IVT Granted U S Patent for LiverPool 28TM 29 Hepatocytes 14543 2

[0] Carvedilol shown to have unique characteristics among beta blockers [0] Sweet corn story begins in UW-Madison lab [0] New maize map to aid plant breeding efforts

...ears scientists have struggled to understand the d...e abundant and highly prized game and food fish na...poor marine survival is affecting salmon in the U....o determine in the ocean. Small acoustic tags and ... Thirty of 150 Atlantic salmon smolts tagged by N...

...NGTON, DCChildren,s National Medical Center immuno... Naynesh Kamani, MD , will serve as the study co-c...d donor marrow and umbilical cord blood transplant...tional will join more than 20 other medical instit...f this treatment. If successful, the Sickle Cell U...

...N, VA (August 18, 2008) Cocoa flavanols, the uniq...e blood flow to the brain, according to new resear...reatment journal. The researchers suggest that lon...ct cognitive behavior, offering future potential f...a and stroke. , ,In a scientific study of healthy,...

Other Biology News:Signals from the Atlantic salmon highway 2 Signals from the Atlantic salmon highway 3 Signals from the Atlantic salmon highway 4 Children's national co-leads nationwide study of landmark sickle cell treatment 2 Researchers link cocoa flavanols to improved brain blood flow 2 Researchers link cocoa flavanols to improved brain blood flow 3

Signals from the Atlantic salmon highway Children's national co-leads nationwide study of landmark sickle cell treatment Researchers link cocoa flavanols to improved brain blood flow

...the chance of error. Thats the safeguard built int...xtensive experience in laboratory automation and l... the CEQ 8000 is a fully automated genetic analysi...llary array with a patented linear polyacrylamide ...

...s a major advance in liquid dispensing technology ...liquid handlers into the realm of the small bencht...from 10mL to 2mL per well, the micro 10 has unique...sers. ,Features: , Never needs re-calibrat...

PerkinElmer Spectrum Beer's Law QUANT Quantitative Software, CD from PerkinElmer

Murashige and Skoog basal salt solution with Gamborg's B5 vitamins, 10X concentrate from Research Organics, Inc.

Biology Products:

CEQ 8000 Genetic Analysis System from Beckman Coulter micro 10 from Hudson Control Group, Inc.PerkinElmer Spectrum Beer's Law QUANT Quantitative Software, CD from PerkinElmer Murashige and Skoog basal salt solution with Gamborg's B5 vitamins, 10X concentrate from Research Organics, Inc.

Vista Partners Updates Coverage; Maintains $3.20 Ta...(absence of drugsof abuse in oral fluids....)